Qulipta 60 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3UQL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,282
Award facts
- Contract value 100% obligated
- $6,281.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,281.80 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count) on January 29, 2026, with completion expected by January 30, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. Qulipta (quillivant extended-release capsules) is a neurological and psychiatric medication used in federal healthcare settings, and this delivery order exemplifies the company's role in fulfilling specialized pharmaceutical requirements across multiple therapeutic domains. The contract's structure as a delivery order under a large-value IDC demonstrates DLA's streamlined procurement approach for managing pharmaceutical supply needs across military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F3UQL?
SPE2DR26F3UQL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F3UQL worth?
The government has obligated $6,282 on SPE2DR26F3UQL.
Is contract SPE2DR26F3UQL an order under another contract?
Yes. SPE2DR26F3UQL is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3UQL competed?
The extent of competition for SPE2DR26F3UQL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award